Investment Thesis
Tenet Healthcare demonstrates strong operational cash flow generation ($1.5B FCF, 27.2% margin) and solid operating efficiency (24.1% margin), but faces significant profitability headwinds with net income down 40.6% YoY and EPS down 52.6% YoY despite modest 3.1% revenue growth. High leverage (2.73x debt/equity, $13.1B long-term debt) combined with deteriorating net profitability raises concerns about financial resilience, though interest coverage remains healthy at 5.9x.
Strengths
- Exceptional free cash flow generation of $1.5B with 27.2% FCF margin
- Solid operating margins of 24.1% demonstrate operational efficiency
- Strong interest coverage ratio of 5.9x provides debt service cushion
- Adequate liquidity with current ratio of 1.36x and $3.0B cash position
- Steady revenue growth of 3.1% YoY in competitive healthcare sector
Risks
- Severe net income decline of 40.6% YoY and EPS decline of 52.6% YoY despite revenue growth signals profitability deterioration
- High leverage with 2.73x debt/equity ratio and $13.1B long-term debt limits financial flexibility
- Large gap between operating income ($1.3B) and net income ($702M) suggests substantial interest expense burden
- Low ROA of 2.2% indicates inefficient asset utilization
- Unknown cause of dramatic profitability decline requires investigation
Key Metrics to Watch
- Net income trend and margin recovery in subsequent quarters
- Operating expense ratio changes to identify cost control issues
- Debt reduction progress and refinancing activities
- Free cash flow sustainability amid profitability challenges
- Operating cash flow conversion ratio
Financial Metrics
Revenue
5.4B
Net Income
702.0M
EPS (Diluted)
$8.01
Free Cash Flow
1.5B
Total Assets
31.2B
Cash
3.0B
Profitability Ratios
Gross Margin
N/A
Operating Margin
24.1%
Net Margin
13.1%
ROE
14.6%
ROA
2.2%
FCF Margin
27.2%
Balance Sheet & Liquidity
Current Ratio
1.36x
Quick Ratio
1.30x
Debt/Equity
2.73x
Debt/Assets
71.6%
Interest Coverage
5.94x
Long-term Debt
13.1B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T19:01:46.388116 |
Data as of: 2026-03-31 |
Powered by Claude AI